Pegasus Partners Ltd. Bio Techne Corp Transaction History

Pegasus Partners Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$322.67 - $449.65 $152,622 - $212,684	-473 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$353.85 - $487.79 $27,954 - $38,535	-79 Reduced 14.31%	473 $205,000
Q4 2021 Feb 09, 2022	SELL	$456.15 - $525.06 $56,562 - $65,107	-124 Reduced 18.34%	552 $286,000
Q3 2021 Nov 12, 2021	SELL	$444.87 - $538.88 $104,544 - $126,636	-235 Reduced 25.8%	676 $328,000
Q2 2021 Aug 13, 2021	BUY	$387.35 - $450.26 $57,327 - $66,638	148 Added 19.4%	911 $410,000
Q1 2021 May 14, 2021	BUY	$314.62 - $411.0 $240,055 - $313,593	763 New	763 $291,000

602

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.87B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Pegasus Partners Ltd., based on Form 13F filings with the SEC.

Stay updated on Pegasus Partners Ltd. with notifications on news.